PTP1B-IN-2 10 mg | 99.58%
TargetMol
PTP1B-IN-2 is an effective protein tyrosine phosphatase 1B (PTP1B) inhibitor(IC50=50 nM).
More Information Supplier PagePTP1B-IN-2
Search Results
PTP1B-IN-2 5 mg | 99.58%
TargetMol
PTP1B-IN-2 is an effective protein tyrosine phosphatase 1B (PTP1B) inhibitor(IC50=50 nM).
More Information Supplier PagePTP1B-IN-2
PTP1B-IN-2 1 mg | 99.58%
TargetMol
PTP1B-IN-2 is an effective protein tyrosine phosphatase 1B (PTP1B) inhibitor(IC50=50 nM).
More Information Supplier PagePTP1B-IN-2
TM5275 sodium 100 mg | 99.55%
TargetMol
TM5275 sodium
TM5275 sodium 50 mg | 99.55%
TargetMol
TM5275 sodium
Buparvaquone 100 mg | 99.60%
TargetMol
Buparvaquone is a hydroxynaphthoquinone antiprotozoal drug related to atovaquone and parvaquone.
More Information Supplier PageBuparvaquone
SRI-011381 2 mg | 99.11%
TargetMol
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer’s disease.
More Information Supplier PageSRI-011381
CD437 2 mg | 99.63%
TargetMol
CD437
SRI-011381 100 mg | 99.11%
TargetMol
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer’s disease.
More Information Supplier PageSRI-011381
SRI-011381 50 mg | 99.11%
TargetMol
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer’s disease.
More Information Supplier PageSRI-011381